Asterias Biotherapeutics, Inc. , a leading biotechnology company in the emerging field of regenerative medicine, today announced that Pedro Lichtinger, President and Chief Executive Officer, will ring The Opening Bell of the New York Stock Exchange tomorrow, Thursday, March 5, 2015. Asterias began trading as an NYSE MKT listed company on October 8, 2014.
http://ift.tt/1AL7gyg
http://ift.tt/1AL7gyg
No comments:
Post a Comment